Get the Stockscreener App
25.12
0.34%
-0.0863
Xoma Corporation stock is traded at $25.12, with a volume of 1,225.
It is down -0.34% in the last 24 hours and down -0.69% over the past month.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
See More
Previous Close:
$25.20
Open:
$25.29
24h Volume:
1,225
Relative Volume:
0.31
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.27%
1M Performance:
-0.69%
6M Performance:
-0.54%
1Y Performance:
+0.16%
1-Day Range:
$25.11
$25.29
1-Week Range:
$25.05
$25.37
52-Week Range:
$23.32
$25.87
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Compare XOMAO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMAO
Xoma Corporation
|
25.12 | 0 | 0 | 0 | 0 | 0.00 |
|
ONC
Beigene Ltd Adr
|
241.43 | 27.03B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 112.64B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 40.86M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 64.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 6.07B | 0 | -153.72M | -103.81M | -2.00 |
Xoma Corporation Stock (XOMAO) Latest News
XOMA (NASDAQ:XOMAO) Stock Price Up 0.1% – Still a Buy? - Defense World
XOMA (NASDAQ:XOMAP) Trading Up 1.5% – Still a Buy? - Defense World
Major Shareholder Sells Massive Chunk of Xoma Stock! - TipRanks
(XOMAP) Investment Report - news.stocktradersdaily.com
Leerink Partnrs Analysts Boost Earnings Estimates for XOMA - Defense World
FY2026 Earnings Estimate for XOMA Issued By Leerink Partnrs - Defense World
Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
(XOMA) Investment Analysis and Advice - news.stocktradersdaily.com
XOMA Royalty First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
XOMA Royalty Reports Strong Q1 2025 Results - TipRanks
XOMA Royalty: Q1 Earnings Snapshot - New Haven Register
XOMA Royalty Corp Q1 2025 Earnings: EPS of $0.24, Revenue Surges to $15.9 Million, Exceeding Estimates - GuruFocus
XOMA (XOMA) Surpasses Q1 Revenue Expectations with Strong Pipeli - GuruFocus
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
XOMA earnings beat by $0.35, revenue topped estimates - Investing.com
XOMA Royalty Corporation Q1 2025 Financial Results - TradingView
XOMA Royalty Corp SEC 10-Q Report - TradingView
XOMA Royalty Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements - GlobeNewswire
Wells Fargo & Company MN Grows Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
Barclays PLC Acquires 1,528 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Royalty Corporation's (NASDAQ:XOMA) 27% Share Price Surge Not Quite Adding Up - simplywall.st
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewswire
XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Trend Tracker for (XOMAO) - news.stocktradersdaily.com
(XOMA) Investment Analysis - news.stocktradersdaily.com
Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World
XOMA Royalty : 2025 Letter to Stockholders - marketscreener.com
How To Trade (XOMAP) - news.stocktradersdaily.com
Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World
Trading (XOMAO) With Integrated Risk Controls - news.stocktradersdaily.com
(XOMA) On The My Stocks Page - news.stocktradersdaily.com
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (LSE:0M26) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
Benchmark Initiates XOMA Royalty at Buy With $35 Price Target - marketscreener.com
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
XOMA Royalty (NASDAQ:XOMA) Is Making Moderate Use Of Debt - simplywall.st
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability - Yahoo
XOMA completes sale of Kinnate assets for up to $270 million By Investing.com - Investing.com South Africa
XOMA completes sale of Kinnate assets for up to $270 million - Investing.com Canada
Xoma Royalty Completes Sale Of Kinnate Pipeline Assets - MarketScreener
XOMA Royalty Completes Sale of Kinnate Pipeline Assets - The Manila Times
XOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 Shares - MarketBeat
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
17.27%
1.06%
Cap:
|
Volume (24h):